Edesa Biotech, Inc.
EDSA· Nasdaq
Edesa Biotech, Inc.
- Last sale
- Oct 2, 2026 · -5.85%
- Market cap
- $37.21M
- 9.64M shares
- Filings
- 745
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2021 | 2021-09-30 | $0 | reported | |
| FY 2020 | 2020-09-30 | $328,801 | reported | |
| FY 2019 | 2018-12-31 | $0 | reported | |
| FY 2018 | 2018-09-30 | $211,849 | reported | |
| FY 2017 | 2017-09-30 | $228,287 | reported | |
| FY 2016 | 2016-09-30 | $1,271,689 | reported | |
| FY 2015 | 2015-09-30 | $758,689 | reported | |
| FY 2014 | 2014-08-31 | $372,132 | reported | |
| FY 2013 | 2013-08-31 | $545,469 | reported | |
| FY 2012 | 2012-08-31 | $286,054 | reported |
Edesa Biotech, Inc. · CIK 1540159 · Engraved from SEC EDGAR
